Attached files
| file | filename |
|---|---|
| 10-Q - 10-Q - FV Pharma International Corp. | f10qalphala121113.htm |
| EXCEL - IDEA: XBRL DOCUMENT - FV Pharma International Corp. | Financial_Report.xls |
| EX-31 - EXHIBIT 31.1 - FV Pharma International Corp. | certification31.htm |
Exhibit 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of ALPHALA CORP. (the "Company") on Form 10-Q for the period ended October 31, 2013 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), the undersigned, in the capacities and on the dates indicated below, hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to his knowledge:
1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: December 11, 2013
/s/ Irina Petrzhikovskaya
__________________________
Irina Petrzhikovskaya , President,
Chief Executive Officer and
Chief Financial Officer